ClinicalTrials.gov
ClinicalTrials.gov Menu

A Comparative Study of the Air-Q ILA and the ILMA for Ventilation and Intubation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01209559
Recruitment Status : Suspended (Study never initiated.)
First Posted : September 27, 2010
Last Update Posted : January 31, 2017
Sponsor:
Information provided by (Responsible Party):
Orlando Hung, Nova Scotia Health Authority

Brief Summary:
The objective of this study is to determine if the glottic view obtained with the air-Q Intubating Laryngeal Airway (air-Q ILA, Cookgas LLC®, Mercury Medical®, Clearwater, FL, USA) is better than that obtained with the traditionally used intubating laryngeal mask airway (LMA FastrachTM or ILMA, LMA North America Inc., San Diego, CA). The study will also compare effectiveness of ventilation.

Condition or disease
Airway Management

Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : January 2011
Actual Primary Completion Date : January 2011

Group/Cohort
air-Q Intubating Laryngeal Airway
LMA FastrachTM or ILMA




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Healthy ASA class I and II patients scheduled for elective surgery under general anesthesia requiring the use of the LMA.
Criteria

Inclusion Criteria:

  • healthy ASA class I and II patients scheduled for elective surgery under general anesthesia requiring the use of the LMA

Exclusion Criteria:

  • history of acid reflux,
  • a BMI ≥ 40kg.m-2,
  • require endotracheal intubation,
  • have predictors of difficult intubation,
  • not candidates for insertion of an ILMA or LMA, including a mouth opening of less than 2.5 cm,
  • cannot consent to the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01209559


Locations
Canada, Nova Scotia
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada, B3H 2Y9
Sponsors and Collaborators
Nova Scotia Health Authority

Responsible Party: Orlando Hung, MD FRCPC, Nova Scotia Health Authority
ClinicalTrials.gov Identifier: NCT01209559     History of Changes
Other Study ID Numbers: CDHA-RS/2011-156
First Posted: September 27, 2010    Key Record Dates
Last Update Posted: January 31, 2017
Last Verified: January 2017